TrialLeukemia & lymphoma2017

Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy.

Roxanne C Jewell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.